Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of Drug-drug Interaction in Korean Healthy Subjects

NCT02328443 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02328443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02328443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of Drug-drug Interaction in Korean Healthy Subjects
Lead sponsor
Seoul National University Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2015
Enrollment
24 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy